onlyRoutes oralDoxazosin mesylate, a quinazoline compound sold by Pfizer under the brand names Cardura® and Carduran® , is an alpha-1 adrenergic receptor blocker which inhibits the binding of norepinephrine to alpha receptors in the autonomic nervous cardura logo The primary effect of this cardura logo is relaxed vascular smooth muscle tone.

Wikipedia, the free cardura logo from Cardura)Jump to: navigation, searchDoxazosinSystematic (IUPAC) cardura logo quinazolin-2-yl) piperazin-1-yl]- (2,5-dioxabicyclo[4.4.0] deca-6,8,10-trien-4-yl) methanoneIdentifiersCAS number 74191-85-8ATC code C02CA04PubChem 3157DrugBank APRD00474Chemical dataFormula C23H25N5O5Mol. mass 451.475 g/molPharmacokinetic dataBioavailability 65%Protein binding 98%Metabolism HepaticHalf life 22 hoursExcretion ?Therapeutic considerationsPregnancy cat. ?Legal status ? Prescription cardura logo oralDoxazosin mesylate, a quinazoline compound sold cardura logo Pfizer under the brand names Cardura® and Carduran® , is an alpha-1 adrenergic receptor blocker which inhibits the binding of norepinephrine to cardura logo receptors in the autonomic nervous system. cardura logo primary effect of this blockage is relaxed vascular smooth muscle tone (vasodilation), which decreases peripheral vascular resistance, leading to decreased blood pressure.

name[4-(4-amino-6,7-dimethoxy- quinazolin-2-yl) piperazin-1-yl]- (2,5-dioxabicyclo[4.4.0] deca-6,8,10-trien-4-yl) methanoneIdentifiersCAS.